USPSTF 2023: Evidence insufficient to recommend lipid screening in children and adolescents (I statement)

Clinical Question

Should primary care clinicians screen asymptomatic children and adolescents for lipid disorders?

Bottom line

The USPSTF found inadequate evidence on the balance of benefits and harms of screening for familial hypercholesterolemia or dyslipidemia in asymptomatic children and adolescents aged 20 years or younger (I statement). Although the task force found no direct evidence of harm, screening could result in further unnecessary or harmful testing and treatment. This review did not address the issue of targeted screening based on family history of premature cardiovascular events. These recommendations are consistent with the 2016 USPSTF statement. 2c

Study design: Practice guideline

Funding: Government

Setting: Various (guideline)

Reviewer

David C. Slawson, MD
Professor and Vice Chair of Family Medicine for Education and Scholarship
Atrium Health
Professor of Family Medicine, UNC Chapel Hill
Charlotte, NC


Discuss this POEM


Comments

ARUP KUMAR DHARA

Impact assessment

Excellent

Lindsay Pritchett

lipid screening in children

Why on earth would you do that?
Maybe if one of your parents had a severe hyperlipidemia problem- but otherwise that seems like looking for a problem where one does not exist.

Anonymous

LIPID SCREENING IN CHILDREN

GOOD TO KNOW